Molecular Analysis Identifies A Subset Of Non-small Cell Lung Cancer Patients With Differential Sensitivity To Histone Deacetylase Inhibitor (hdaci)/Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (egfr-tki) Treatment

被引：0
|
作者：
Jotte, R. M. [1 ]
Witta, S. E. [2 ]
Spira, A. I. [3 ]
Neubauer, M. A. [4 ]
Konduri, K. [5 ]
Ruxer, R. L. [6 ]
Hirsch, F. R. [7 ]
机构：
[1] Rocky Mt Canc Ctr, Denver, CO USA
[2] Mt Blue Canc Care Ctr, Wheat Ridge, CO USA
[3] Virginia Canc Specialists, INOVA Thorac Oncol Program, Fairfax, VA USA
[4] Kansas City Canc Ctr, Overland Pk, KS USA
[5] Baylor Sammons Canc Ctr, Dallas, TX USA
[6] SW Ft Worth Canc Ctr, Ft Worth, TX USA
[7] Univ Colorado, Ctr Canc, Aurora, CO USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2010年 / 5卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S559 / S560
页数：2
相关论文
共 50 条
  • [1] SYNERGISTIC EFFECT OF HISTONE DEACETYLASE INHIBITOR IN COMBINATION WITH EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITOR IN EGFR-TKI RESISTANT NON-SMALL CELL LUNG CANCER CELL LINES
    Han, X.
    Zhang, N.
    Yao, J.
    Shi, Y.
    ANNALS OF ONCOLOGY, 2015, 26
  • [2] EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITOR (EGFR-TKI) RELATED INTERSTITIAL LUNG DISEASE IN TAIWANESE PATIENTS WITH NON-SMALL CELL LUNG CANCER
    Chiang, Chi-Lu
    Tsai, Chun-Ming
    Lee, Yu-Chin
    Chiu, Chao-Hua
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S592 - S592
  • [3] Dacomitinib, a second-generation irreversible epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) to treat non-small cell lung cancer
    Nagano, T.
    Tachihara, M.
    Nishimura, Y.
    DRUGS OF TODAY, 2019, 55 (04) : 231 - 236
  • [4] Neoadjuvant and adjuvant epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) therapy for lung cancer
    Zhai, Haoran
    Zhong, Wenzhao
    Yang, Xuening
    Wu, Yi-Long
    TRANSLATIONAL LUNG CANCER RESEARCH, 2015, 4 (01) : 82 - 93
  • [5] Efficacy, Safety And Dosage Of Afatinib In Patients With Non-Small Cell Lung Cancer After Failure Of Prior Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-Tki)
    Park, C.
    Kim, T.
    Shin, H.
    Ban, H.
    Lim, J.
    Kwon, Y.
    Oh, I.
    Kim, Y.
    Lim, S.
    Kim, Y.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [6] Antitumor Efficacy of Histone Deacetylase Inhibitor or in Combination with EGFR-TKI in Non-Small Cell Lung Cancer Cell Lines
    Han, Xiaohong
    Zhang, Ningning
    Yao, Jiarui
    Shi, Yuankai
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S484 - S484
  • [7] ECONOMIC EVALUATION OF EPIDERMAL GROWTH FACTOR RECEPTOR - TYROSINE KINASE INHIBITOR (EGFR-TKI) DRUGS IN NON-SMALL CELL LUNG CANCER (NSCLC) TREATMENT: A SYSTEMATIC REVIEW OF RECENT STUDIES
    Karim, M.
    Nabil, A. K.
    Khodakarami, N.
    Kum, H. C.
    Foster, M. J.
    Ohsfeldt, R. L.
    VALUE IN HEALTH, 2020, 23 : S46 - S46
  • [8] Rare and complex mutations of epidermal growth factor receptor (EGFR) and efficacy of tyrosine kinase inhibitor (TKI) in patients with non-small cell lung cancer (NSCLC).
    Keam, Bhumsuk
    Kim, Dong-Wan
    Park, Jin Hyun
    Lee, Jeong-Ok
    Kim, Tae Min
    Lee, Se-Hoon
    Jeon, Yoon-Kyung
    Chung, Doo Hyun
    Heo, Dae Seog
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [9] Smoking history, drug toxicity, and survival in non-small cell lung cancer (NSCLC) patients receiving epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) drugs
    Cooley, M. E.
    Emmons, K. M.
    Li, H.
    Harrington, D. P.
    Christiani, D. C.
    Jackman, D. M.
    Cohen, T.
    Johnson, B. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [10] A PILOT STUDY OF A STEROID SULPHATASE INHIBITOR (BN83495) IN PATIENTS WITH RASH DUE TO TREATMENT WITH AN ORAL EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITOR (EGFR-TKI) FOR NON-SMALL CELL LUNG CANCER (NSCLC)
    Mileshkin, Linda
    Mccormack, Chris
    Michael, Michael
    Solomon, Ben
    Urban, Damien
    Link, Emma
    Cowan, Linda
    Zalcberg, John
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1020 - S1020
12345